2026 ACVR Banner

Call for Abstracts Now Open

The 2026 Annual Conference on Vaccinology Research, hosted by the National Foundation for Infectious Diseases (NFID), provides a platform for all those interested in vaccinology—from early-career researchers to seasoned scientists—to reach influential experts in vaccinology with your latest research.  

Submit your abstract as a rapid-fire oral presentation for high visibility during a scheduled oral abstract session. Don’t miss this chance to boost your career and contribute to the future of vaccinology.

We are accepting submissions on topics, including:

    • Combating Antimicrobial Resistance  
    • Implementation Challenges and Solutions (Behavioral Science, Safety, Monitoring, Evaluation, Policy, and Regulatory Pathways)  
    • Innovation in Immunization (Vaccine Research, Development, Production, and Delivery)  
    • Protecting High-Risk Populations (Maternal Immunization, Immunocompromised, and High-Risk Groups)  
    • Immunization Disparities and Health Equity  
    • Vaccines against Emerging and Re-Emerging Infectious Diseases  

 

Why Submit for Presentation?
    • Career Growth: Present your research and insights to enhance your professional development, engage in meaningful discussions, and connect with experts in vaccinology 
    • Recognition: Showcase research to a diverse audience of clinicians, public health professionals, and leading vaccine scientists 
    • Expand Your Reach in Vaccinology: Present your innovative research to vaccinology leaders from industry, academia, and government organizations to help advance future vaccine recommendations and public health strategies 

 

Important Deadlines
March 2026 Call for Abstracts submission site opens
Rolling Review Abstracts will be reviewed within 3 weeks of submission
May 22, 2026 Call for Abstracts closes

About the Conference

The Annual Conference on Vaccinology Research brings together the diverse disciplines involved in vaccine research, development, implementation, and real-world evaluation.

The 2026 program is designed to facilitate discussion and collaboration around emerging innovations and breakthroughs in vaccinology, while recognizing the evolving regulatory environment and public dialogue surrounding vaccines.

For more than 25 years, the event has been well-regarded by attendees as a unique forum for relevant discussions and interdisciplinary collaborations between scientists and researchers, healthcare professionals, government, industry, and academia.

Questions? Email: vaccine@nfid.org

ACVR 1-Web

"So much valuable information is always provided during this conference. It's one of my favorites each year. "

--Past ACVR Attendee

Continuing Education and Learning Objectives

ACVR Posters

Overall Conference Learning Objectives

At the conclusion of this activity, participants will be able to:

    • Discuss recent scientific advances contributing to vaccine research, development, implementation, and real-world evaluation
    • Identify novel research opportunities and scientific challenges associated with vaccine development, implementation, and real-world evaluation
    • Evaluate the role of immunization in preventing and mitigating existing, emerging, and re-emerging infectious diseases

2026 Conference Planning Committee

A woman in a face mask gives a thumbs up while getting vaccinated

Monica M. Farley, MD

Robert H. Hopkins, Jr., MD

Robert H. Hopkins, Jr., MD

Orin S. Levine Receiving Vaccine

Orin S. Levine, PhD

Seema U. Nayak, MD